Ronit Gross - BioLight Life CoFounder
| BOLT Stock | ILS 505.00 6.00 1.20% |
Insider
Ronit Gross is CoFounder of BioLight Life Sciences
| Phone | 972 7 327 53400 |
| Web | https://bio-light.co.il |
BioLight Life Management Efficiency
The company has return on total asset (ROA) of (0.0925) % which means that it has lost $0.0925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0911) %, meaning that it generated substantial loss on money invested by shareholders. BioLight Life's management efficiency ratios could be used to measure how well BioLight Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Deborah Griffin | Teva Pharmaceutical Industries | N/A | |
| Yaacov Kagan | Elbit Systems | N/A | |
| Elias MD | Opko Health | 72 | |
| Dani Ashkenazi | Tower Semiconductor | 60 | |
| Janet Vergis | Teva Pharmaceutical Industries | 54 | |
| Andrew Weil | Teva Pharmaceutical Industries | 52 | |
| Arie Gutman | Opko Health | 69 | |
| Jerry Neal | Tower Semiconductor | 74 | |
| Rami Myerson | Elbit Systems | N/A | |
| Noit LevyKaroubi | Tower Semiconductor | 38 | |
| Abbas Hussain | Teva Pharmaceutical Industries | 54 | |
| Kare Schultz | Teva Pharmaceutical Industries | 62 | |
| Ariella Raban | Kamada | 48 | |
| Yoav Chelouche | Tower Semiconductor | 66 | |
| James DeMarco | Opko Health | N/A | |
| Haim Delmar | Elbit Systems | 49 | |
| Jon MD | Opko Health | 68 | |
| Eran Nir | Kamada | 51 | |
| Amir Weiss | Teva Pharmaceutical Industries | 46 | |
| Kathleen Veit | Teva Pharmaceutical Industries | N/A | |
| Ronit SatchiFainaro | Teva Pharmaceutical Industries | 46 | |
Management Performance
| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 |
BioLight Life Sciences Leadership Team
Elected by the shareholders, the BioLight Life's board of directors comprises two types of representatives: BioLight Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLight. The board's role is to monitor BioLight Life's management team and ensure that shareholders' interests are well served. BioLight Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLight Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yifftach CPA, Chief Officer | ||
| Ronit Gross, CoFounder | ||
| Karin Gurevitz, Vice President General Counsel, Secretary | ||
| Ron MD, Chief Board | ||
| Yaacov Michlin, Chief Officer |
BioLight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioLight Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 | |||
| Current Valuation | 13.59 M | |||
| Shares Outstanding | 4.56 M | |||
| Shares Owned By Insiders | 56.36 % | |||
| Shares Owned By Institutions | 9.12 % | |||
| Price To Earning | 82.18 X | |||
| Price To Book | 0.61 X | |||
| Price To Sales | 4,937 X | |||
| Revenue | 3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BioLight Stock
BioLight Life financial ratios help investors to determine whether BioLight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLight with respect to the benefits of owning BioLight Life security.